Trial NCT04258683

View at ClinicalTrials.gov 
Org. Study IDs: CMRG 006
Secondary IDs: WINNIPEG

Last trial update was posted on 2023-08-29

MeSH Interventions

Pembrolizumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Study terminated due to changing treatment landscape

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID